| View |
|
DRP-12401
|
Gemcitabine (as hydrochloride)
|
Gecita-200
|
200 mg
|
Lyophilized Powder for I.V. Infusion
|
Antineoplastic (Pyrimidine Analogue)
|
ADMAC Lifesciences
|
India
|
Initial
|
02 August 2022
|
02 August 2027
|
| View |
|
DRP-12400
|
Gemcitabine (As Hydrochloride)
|
Gecita
|
1 g
|
Lyophilized Powder for I.V. Infusion
|
Antineoplastic (Pyrimidine Analogue)
|
ADMAC Lifesciences
|
India
|
Initial
|
02 August 2022
|
02 August 2027
|
| View |
|
DRP-12398
|
Fluticasone Propionate
|
Flomist
|
50 mcg
|
actuation Aqueous Nasal Spray
|
Nasal Corticosteroid
|
Cipla Ltd.
|
India
|
Initial (Reconstruction)
|
31 July 2024
|
01 August 2027
|
| View |
|
DRP-8574
|
Paracetamol + Orphenadrine Citrate
|
Paradrin Forte
|
650 mg / 50 mg
|
Tablet
|
-
|
Tabros Pharma (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
03 June 2021
|
28 November 2026
|
| View |
|
DRP-4465-05
|
Amino acids + Sorbitol
|
Aminocent
|
(See reverse for formulation)
|
Solution for Infusion (IV)
|
Amino acids
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd
|
China
|
Renewal
|
15 December 2022
|
12 December 2027
|
| View |
|
DRP-6051-17
|
Ketoanalogues + Essential Amino Acids
|
Ketomicore
|
(See reverse for Unit Dose Formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
04 August 2024
|
13 March 2030
|
| View |
|
DRP-6700-02
|
Amoxicillin (as trihydrate)
|
AMOXICOLLEN
|
100 mg/mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
22 August 2022
|
18 May 2026
|
| View |
|
DRP-8044
|
Tobramycin
|
Tobrin
|
3 mg/mL (0.3 % w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
Renewal
|
22 August 2022
|
05 December 2028
|
| View |
|
DRP-10152-01
|
Meropenem (as trihydrate)
|
Amsopen
|
1 g
|
powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
22 August 2022
|
05 September 2028
|
| View |
|
DRP-10246-03
|
Ceftriaxone (as sodium)
|
EFXONE
|
1 g
|
Powder for Injection
|
Antibacterial (Third-Generation Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
22 August 2022
|
01 October 2026
|
| View |
|
DRP-10512-11
|
Febuxostat
|
Zure-Uric
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
22 August 2022
|
07 October 2026
|
| View |
|
DRP-11154-14
|
Nicardipine Hydrochloride
|
Nicasan
|
1mg/mL (10mg/10mL)
|
Solution for Injection (IV Infusion)
|
calcium Channel Blocker (Dihydropyridine Derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
22 August 2022
|
11 February 2027
|
| View |
|
DRP-11492-02
|
Omeprazole (as sodium)
|
BLISSPRAZOLE, OMEPBLISS, BLIZOLE
|
40mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Proton Pump Inhibitor (PPI)
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
22 August 2022
|
17 March 2027
|
| View |
|
DRP-12239-01
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Montephil-L
|
10 mg/ 5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
22 August 2022
|
07 July 2027
|
| View |
|
DR-XY27814
|
Cotrimoxazole
|
Zolmed Forte
|
400 mg/80 mg per 5 mL
|
Suspension
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 August 2022
|
04 September 2027
|
| View |
|
DRP-12485
|
Aceclofenac + Paracetamol
|
Zerodol-P
|
100mg/500mg
|
Film-Coated Tablet
|
-
|
Ipca Laboratories Limited
|
India
|
PCPR Conversion
|
22 August 2022
|
05 February 2026
|
| View |
|
DRP-12486
|
Aceclofenac
|
Zerodol-CR
|
200 mg
|
Controlled-Release Tablet
|
-
|
Ipca Laboratories Limited
|
India
|
PCPR Conversion
|
22 August 2022
|
05 February 2026
|
| View |
|
DRP-12500
|
Hydroxychloroquine sulfate
|
HCQS
|
200mg
|
Film-Coated Tablet
|
-
|
Ipca Laboratories Limited
|
India
|
PCPR Conversion
|
22 August 2022
|
02 June 2027
|
| View |
|
DRP-8450
|
Amoxicillin (as Trihydrate)
|
Westfimox
|
100 mg/mL
|
Powder for Suspension (Oral Drops)
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
23 August 2022
|
30 September 2027
|
| View |
|
DRP-6275-01
|
Co-Amoxiclav
|
Euroclav
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Combination of penicillin and beta-lactamase inhibitor)
|
UniMedicolabs
|
India
|
Automatic Renewal
|
29 May 2023
|
05 June 2028
|